BIOMAT Database Logo BIOMAT Database Logo

Rubella immunization: long-term observation of antibody titers. 1973

E L Kwik, and A B Kenny, and W H Hitzig

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E L Kwik, and A B Kenny, and W H Hitzig
[Variation of antibody titers following rubella immunization].
April 1975, Nihon eiseigaku zasshi. Japanese journal of hygiene,
E L Kwik, and A B Kenny, and W H Hitzig
Long-term observation of antibody titers against SARS-CoV-2 following vaccination.
December 2022, Public health in practice (Oxford, England),
E L Kwik, and A B Kenny, and W H Hitzig
Antibody titers after dpt immunization.
April 1982, Hospital practice (Hospital ed.),
E L Kwik, and A B Kenny, and W H Hitzig
Persistence of Anti-Rubella Immunoglobulin G Antibody Titers in Young Adults Involved in a Short-Term Periodic Immunization in Japan.
September 2021, Japanese journal of infectious diseases,
E L Kwik, and A B Kenny, and W H Hitzig
Rubella antibody persistence after immunization.
January 1982, JAMA,
E L Kwik, and A B Kenny, and W H Hitzig
Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation.
March 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
E L Kwik, and A B Kenny, and W H Hitzig
Rubella screening and immunization of schoolgirls: a long-term evaluation.
February 1974, British journal of preventive & social medicine,
E L Kwik, and A B Kenny, and W H Hitzig
Declining antibody titers in children with congenital rubella.
August 1969, The Journal of pediatrics,
E L Kwik, and A B Kenny, and W H Hitzig
[Antibody determination prior to rubella immunization].
July 1973, Deutsche medizinische Wochenschrift (1946),
E L Kwik, and A B Kenny, and W H Hitzig
Quinine-induced purpura. Observation on antibody titers.
July 1967, Archives of internal medicine,
Copied contents to your clipboard!